Medicare Enrolled
Dr. Debralynne Zickafoose, M.D.
Internal Medicine · Murrieta, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zickafoose from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zickafoose?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zickafoose
Dr. Debralynne Zickafoose is an internal medicine specialist in Murrieta, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zickafoose performed 3,004 Medicare services across 2,082 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zickafoose received a total of $5,708 from 34 pharmaceutical and/or device companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zickafoose is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in CA
$5,708 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,004
Medicare services
Top 10% in CA for internal medicine
2,082
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~150 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,126 | $96 | $270 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
694 | $61 | $192 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
192 | $133 | $278 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
176 | $3 | $10 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
112 | $2 | $10 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
110 | $83 | $178 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 82 | $20 | $30 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
82 | $32 | $60 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
72 | $11 | $31 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
61 | $282 | $512 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
61 | $32 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $96 | $353 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
39 | $11 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $144 | $381 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
27 | $42 | $111 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
25 | $0 | $10 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
22 | $34 | $101 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
16 | $170 | $353 |
| New patient office visit, complex (60-74 min) | 11 | $125 | $466 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
11 | $37 | $193 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,708
Total received (2018-2024)
Avg $815/year across 7 years
Top 15% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,708 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,297
2023
$1,638
2022
$1,525
2021
$708
2020
$340
2019
$107
2018
$93
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$399
AstraZeneca Pharmaceuticals LP
$172
Novo Nordisk Inc
$88
Amgen Inc.
$78
Sumitomo Pharma America, Inc.
$67
PFIZER INC.
$66
Novartis Pharmaceuticals Corporation
$58
Astellas Pharma US Inc
$56
Lilly USA, LLC
$45
Exact Sciences Corporation
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Otsuka America Pharmaceutical, Inc.
$40
GlaxoSmithKline, LLC.
$36
Dexcom, Inc.
$28
Optinose US, Inc.
$28
Daiichi Sankyo Inc.
$23
Antares Pharma, Inc.
$18
Lundbeck LLC
$17
Top 3 companies account for 50.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$682
ABBVIE INC.
$486
AstraZeneca Pharmaceuticals LP
$461
GlaxoSmithKline, LLC.
$452
PFIZER INC.
$348
Lilly USA, LLC
$331
Novartis Pharmaceuticals Corporation
$330
Boehringer Ingelheim Pharmaceuticals, Inc.
$280
AbbVie Inc.
$279
IDORSIA PHARMACEUTICALS US INC
$255
Bayer HealthCare Pharmaceuticals Inc.
$251
Bayer Healthcare Pharmaceuticals Inc.
$241
Amgen Inc.
$186
Janssen Pharmaceuticals, Inc
$158
Silk Road Medical, Inc.
$133
Boston Scientific Corporation
$93
Merck Sharp & Dohme LLC
$81
Otsuka America Pharmaceutical, Inc.
$79
Daiichi Sankyo Inc.
$78
Sumitomo Pharma America, Inc.
$67
Exact Sciences Corporation
$59
Astellas Pharma US Inc
$56
Abbott Laboratories
$49
Eisai Inc.
$47
Merck Sharp & Dohme Corporation
$41
Dexcom, Inc.
$28
Optinose US, Inc.
$28
Alexion Pharmaceuticals, Inc.
$24
Bausch Health US, LLC
$23
Kowa Pharmaceuticals America, Inc.
$19
Antares Pharma, Inc.
$18
Lundbeck LLC
$17
SANOFI-AVENTIS U.S. LLC
$16
MannKind Corporation
$13
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · ANORO ELLIPTA · APLENZIN · AREXVY · BAQSIMI · BELSOMRA · BREZTRI · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENROUTE Transcarotid Stent · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · GEMTESA · GENERAL THERAPIES · GENERAL THROMBECTOMY · HUMIRA · INJECTAFER · INNOVA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · Livalo · MOUNJARO · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PREVNAR 13 · PREVNAR 20 · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Strensiq · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VRAYLAR · Veozah · XARELTO · XYOSTED · Xhance
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
607
Per 100K population
24.8
County median income
$89,672
Nearest hospital
SOUTHWEST HEALTHCARE RANCHO SPRINGS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zickafoose is a clinical cardiology specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zickafoose experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zickafoose performed 1,126 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zickafoose receive payments from pharmaceutical companies?
Yes. Dr. Zickafoose received a total of $5,708 from 34 companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zickafoose's costs compare to other internal medicine physicians in Murrieta?
Dr. Zickafoose's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zickafoose) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Murrieta
Browse internal medicine physicians in Murrieta ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology